Fukui Prefectural Hospital
Fukui 910-8526
1 studies enrolling now · 10 studies all time
What they study most
Acute Myocardial Infarction, Atrial Fibrillation, Chronic Heart Failure With Preserved Ejection Fraction, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Heart Failure, Moderately to Severely Active Crohns Disease, Non-Small Cell Lung Cancer, Prevention of Stroke or Systemic Embolism, Spinal Muscular Atrophy (SMA)
Studies at this site
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) — Recruiting now
- Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
- EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
- Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack — Completed
- A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR) — Completed
- Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed
- A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction — Completed